O-[4-(Methylsulfonyl)benzyl]hydroxylamine | 443986-18-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: O-[4-(Methylsulfonyl)benzyl]hydroxylamine
• 英文别名: O-[(4-methylsulfonylphenyl)methyl]hydroxylamine
• CAS: 443986-18-3
• 化学式: C₈H₁₁NO₃S
• 分子量: 201.246
• InChiKey: YJTZBNUYXDBJEF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.1
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  77.8
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-methyl-2-propanyl (2,3-dioxo-2,3-dihydro-1H-indol-1-yl)acetate 、 O-[4-(Methylsulfonyl)benzyl]hydroxylamine 在 对甲苯磺酸 作用下， 以 甲醇 为溶剂， 生成
  参考文献：
  名称：

  Respiratory syncytial virus fusion inhibitors. Part 7: Structure–activity relationships associated with a series of isatin oximes that demonstrate antiviral activity in vivo

  摘要：

  A series of bezimidazole-isatin oximes were prepared and profiled as inhibitors of respiratory syncytial virus (RSV) replication in cell culture. Structure-activity relationship studies were directed toward optimization of antiviral activity, cell permeability and metabolic stability in human liver micorosomes (HLM). Parallel combinatorial synthetic chemistry was employed to functionalize isatin oximes via O-alkylation which quickly identified a subset of small, lipophilic substituents that established good potency for the series. Further optimization of the isatin oxime derivatives focused on introduction of nitrogen atoms to the isatin phenyl ring to provide a series of aza-isatin oximes with significantly improved PK properties. Several aza-isatin oximes analogs displayed targeted metabolic stability in HLM and permeability across a confluent monolayer of CaCo-2 cells. These studies identified several compounds, including 18i, 18j and 18n that demonstrated antiviral activity in the BALB/c mouse model of RSV infection following oral dosing. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2009.06.030

文献信息

• INHIBITORS OF FLAVIVIRIDAE VIRUSES
  申请人：CANALES Eda

  公开号：US20110178058A1

  公开（公告）日：2011-07-21

  Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections.

  提供的是I式化合物： 及其药用可接受的盐和酯。所提供的化合物、组合物和方法对于治疗黄病毒科病毒感染，特别是丙型肝炎感染，是有用的。
• Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
  申请人：——

  公开号：US20020099208A1

  公开（公告）日：2002-07-25

  The present invention concerns antiviral compounds, their methods of preparation and their compositions, and use in the treatment of viral infections. More particularly, the invention provides heterocyclic substituted 2-methylbenzimidazole derivatives for the treatment of respiratory syncytial virus infection.

  本发明涉及抗病毒化合物，其制备方法及其组合物，以及在治疗病毒感染中的应用。更具体地，本发明提供了用于治疗呼吸道合胞病毒感染的杂环取代的2-甲基苯并咪唑衍生物。
• TETRAHYDROISOQUINOLIN-1-ONE DERIVATIVE OR SALT THEREOF
  申请人：Hisamichi Hiroyuki

  公开号：US20100227866A1

  公开（公告）日：2010-09-09

  [Problems] To provide a pharmaceutical, in particular a compound which can be used as a therapeutic agent for irritable bowel syndrome (IBS). [Means for Solving Problems] It was found that a tetrahydroisoquinolin-1-one derivative having an amide group at the 4-position or a pharmaceutically acceptable salt thereof has an excellent bombesin 2 (BB2) receptor antagonistic action. It is also found that the tetrahydroisoquinolin-1-one derivative is highly effective on bowel movement disorders. From the above, the tetrahydroisoquinolin-1-one derivative of the present invention is useful as a therapeutic agent for diseases associated with a BB2 receptor, in particular IBS.

  [问题] 提供一种药物，特别是一种可用作治疗肠易激综合征（IBS）的治疗剂。 [解决问题的方法] 发现一种在4位具有酰胺基团或其药学上可接受的盐的四氢异喹啉-1-酮衍生物具有优异的肽释放因子2（BB2）受体拮抗作用。还发现四氢异喹啉-1-酮衍生物对肠道运动障碍非常有效。由此可见，本发明的四氢异喹啉-1-酮衍生物对与BB2受体相关的疾病，特别是IBS，具有治疗剂的用途。
• Tetrahydroisoquinolin-1-one derivative or salt thereof
  申请人：Seldar Pharma Inc.

  公开号：US10016410B2

  公开（公告）日：2018-07-10

  To provide a pharmaceutical, in particular a compound which can be used as a therapeutic agent for irritable bowel syndrome (IBS). It was found that a tetrahydroisoquinolin-1-one derivative having an amide group at the 4-position or a pharmaceutically acceptable salt thereof has an excellent bombesin 2 (BB2) receptor antagonistic action. It is also found that the tetrahydroisoquinolin-1-one derivative is highly effective on bowel movement disorders. From the above, the tetrahydroisoquinolin-1-one derivative of the present invention is useful as a therapeutic agent for diseases associated with a BB2 receptor, in particular IBS.

  提供一种药物，特别是一种可用作肠易激综合征（IBS）治疗剂的化合物。研究发现，一种在 4 位具有酰胺基团的四氢异喹啉-1-酮衍生物或其药学上可接受的盐具有很好的蚕豆素 2（BB2）受体拮抗作用。研究还发现，四氢异喹啉-1-酮衍生物对肠道运动障碍也有很好的疗效。综上所述，本发明的四氢异喹啉-1-酮衍生物可作为一种治疗剂，用于治疗与 BB2 受体相关的疾病，特别是肠易激综合征。
• HETEROCYCLIC SUBSTITUTED 2-METHYL-BENZIMIDAZOLE ANTIVIRAL AGENTS
  申请人：BRISTOL-MYERS SQUIBB COMPANY

  公开号：EP1343499A2

  公开（公告）日：2003-09-17